Seres Therapeutics Inc (MCRB) Q3 2024 Earnings Call Highlights: Strategic Moves and Clinical ...

By Yahoo! Finance | Nov 14, 2024 at 02:13 AM EST

To learn more about expanding C 155 into additional patient populations like auto HSCT and cancer neutropenia, refer to the full earnings call transcript. C 155's mechanism applies to both allo and auto HSCT, possibly through a basket trial. Partnerships may be considered to speed up efforts.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.